Home > Newsletters > FDAnews Drug Daily Bulletin > Side-by-Side Industry-Academic Partnerships Are Wave of Future
FDAnews Drug Daily Bulletin
Aug. 23, 2012 | Vol. 9 No. 166
Side-by-Side Industry-Academic Partnerships Are Wave of Future
To meet the dual challenges of drug discovery — developing new compounds faster and at less cost — drugmakers should consider forming more integrated partnerships where company staff and academic scientists work side-by-side, one expert suggests. “It’s the best way to ensure benefit on investment,” Kenneth Kaitin, director of the Tufts Center for the Study of Drug Development, said.
Clinical Trials Advisor
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.